EU Clinical Trials Delayed By Poor Reference Safety Information
Executive Summary
EU regulators are increasingly raising objections over the reference safety information that companies include in their clinical trial applications and updated investigator's brochures.
You may also be interested in...
Incorrect Use Of Reference Safety Info Still An Issue, Says UK MHRA
UK good clinical practice inspectors are continuing to detect critical shortcomings relating to clinical trials safety and the management of reference safety information.
UK MHRA Takes Companies To Task Over Trial Safety Information Reporting
Sponsors of clinical trials in the EU have recently been inundated with objections from regulators for incorrectly managing their clinical trial reference safety information, which in turn has resulted in these trials being significantly delayed. A UK MHRA inspector discusses some of the common issues identified during inspections on this front.
Elusive EU Clinical Trial Rules Slip Again -This Time To Late 2018
The schedule for getting the EU's clinical trial portal and database up and running seems to have slipped again, this time by almost a year compared with earlier estimates. As currently forecast, the new system is not likely to be in place, or the provisions of the new Clinical Trial Regulation (CTR) in effect, until the autumn of 2018.